Sarepta Therapeutics (SRPT) PT Raised to $174 at UBS

August 4, 2023 9:15 AM EDT
Get Alerts SRPT Hot Sheet
Price: $19.16 -0.31%

Rating Summary:
    19 Buy, 18 Hold, 6 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UBS analyst Colin Bristow raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $174.00 (from $173.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change